FineMark National Bank & Trust’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

FineMark National Bank & Trust’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-95	Closed	-$3K	–	1505
2015 Q1	$3K	Hold	95	–	–	﹤0.01%	1228
2014 Q4	$3K	Hold	95	–	–	﹤0.01%	1252
2014 Q3	$3K	Hold	95	–	–	﹤0.01%	1231
2014 Q2	$3K	Hold	95	–	–	﹤0.01%	1265
2014 Q1	$3K	Hold	95	–	–	﹤0.01%	1261
2013 Q4	$2K	Hold	95	–	–	﹤0.01%	1348
2013 Q3	$3K	Hold	95	–	–	﹤0.01%	1220
2013 Q2	$3K	Buy	+95	New	+$2.62K	﹤0.01%	1228

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

FineMark National Bank & Trust's BRLI Position: Q2 2015 in Review

FineMark National Bank & Trust sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 95 shares — an estimated $3K sold.

FineMark National Bank & Trust first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $3K in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

FineMark National Bank & Trust reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 95 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $3K.
FineMark National Bank & Trust first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
FineMark National Bank & Trust's BIO-REFERENCE LABS INC-NEW- position peaked at $3K in Q1 2015.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on FineMark National Bank & Trust's 13F filing for Q2 2015, filed 11 Aug 2015.